Hot Tub Lung: Misdiagnosed Hypersensitivity Pneumonitis Revealing a Mycobacterial Aetiology—A Case Report and Literature Review Authors: Fadi Abualhommos, Rahaf Fetyani, Yasmeen Butt, Michael Gotway, Abeer Almajali, Jehad Azar Published: 2026 ABSTRACT ABSTRACTHot tub lung (HTL) is a rare granulomatous pneumonitis caused by inhalational exposure to Mycobacterium avium complex (MAC)‐contaminated hot tub water, with debated pathogenesis encompassing both hypersensitivity and infectious mechanisms. A 66‐year‐old woman with progressive exertional dyspnea was initially misdiagnosed with non‐fibrotic hypersensitivity pneumonitis attributed to pheasant exposure and treated with corticosteroids and mycophenolate without improvement. High‐resolution CT demonstrated diffuse centrilobular nodules with air‐trapping. Surgical lung biopsy revealed bronchiolocentric non‐necrotizing granulomas with rare MAC organisms despite negative bronchoalveolar lavage cultures. Detailed clinical history disclosed daily indoor hot tub use coinciding with symptom onset. Following hot tub cessation and initiation of azithromycin, ethambutol and rifabutin, she ultimately achieved complete clinical and radiologic resolution. HTL represents a heterogeneous spectrum from immune‐mediated hypersensitivity to true mycobacterial infection. Persistent interstitial lung disease despite ongoing immunosuppression should prompt a thorough hot tub exposure history and selected patients may require antimycobacterial therapy alongside exposure cessation.Keywords: granulomatous pneumonitis, hot tub lung, hypersensitivity pneumonitis, Mycobacterium avium complex, nontuberculous mycobacterial infection Introduction Hot tub lung (HTL) is a form of granulomatous pneumonitis secondary to inhalational exposure to Mycobacterium avium complex (MAC) organisms contaminating hot tub water [1, 2]. It presents as diffuse centrilobular nodules, ground‐glass opacities and air trapping on high resolution computed tomography (HRCT), with bronchiolocentric non‐necrotizing granulomas on lung biopsy [3]. Clinically, patients present with subacute cough and exertional dyspnea following prolonged exposure and they usually improve after strict cessation of hot‐tub use, although a minority show persistent disease despite avoidance and immunosuppression [4]. The pathogenesis remains debated, with evidence supporting both a hypersensitivity pneumonitis–like immune response to aerosolized MAC and a possible infectious component [4, 5, 6]. Our case describes chronic daily exposure with histologic detection of rare MAC organisms, illustrating the spectrum and possible coexistence between hypersensitivity and infection, emphasising the diagnostic and therapeutic complexity of this uncommon disease. Our case is distinctive due to prolonged misdiagnosis by competing antigens, BAL/biopsy discordance and immunosuppression failure requiring antimycobacterials. Case Report A 66‐year‐old woman, previous medical history remarkable for chronic kidney disease, systemic hypertension, hyperlipidemia, osteoporosis and factor 5 Leiden mutation was referred to our pulmonary clinic in August 2025 for progressive dyspnea on exertion. She had no history of asthma, smoking or chronic lung disease. Her medications included mycophenolic acid, prednisone 10 mg, alendronate, rosuvastatin, escitalopram, alprazolam and denosumab for osteoporosis. The patient was diagnosed with non‐fibrotic hypersensitivity (HP) in June 2023 (Figure 1A,B), after she suffered from flu‐like symptoms followed by dyspnea on exertion and oxygen desaturation. Axial unenhanced chest CT at presentation through the carina (A) and lower lungs (B) shows continued centrilobular ground‐glass opacities nodules (arrowheads) consistent with a bronchiolocentric interstitial pneumonia pattern as well as bilateral lower lobe geographic hypoattenuation (curved arrows) consistent with mosaic attenuation, suggesting gas trapping. Axial unenhanced chest CT through the carina (C) and lower lungs (D) following counselling regarding hot tub exposure and immunosuppressive therapy, 14 months after presentation, shows continued centrilobular ground‐glass opacities nodules (arrowheads) consistent with a bronchiolocentric interstitial pneumonia pattern as well as bilateral lower lobe geographic hypoattenuation consistent with mosaic attenuation (curved arrows), again suggesting gas trapping. Findings are similar to presentation CT (A and B). Axial unenhanced chest CT through the carina (E) and lower lungs (F) 24 months after presentation and following institution of antimicrobial therapy shows complete resolution of the previously noted abnormalities. Her HP diagnosis was attributed to residential exposure to bird antigens (pheasants) and microbial contaminants from mouldy hay. She was started on prednisone and mycophenolate, but prednisone‐related side effects prompted tapering to 10 mg and daily mycophenolic acid was begun. Despite immunosuppression, repeat imaging showed persistence of previously noted abnormalities (Figure 1C,D) and she suffered recurrent admissions for acute hypoxic respiratory failure, most recently in September 2024. At the time of presentation to our clinic, she reported frequent episodes of flu‐like illness with dyspnea on moderate exertion and a chronic occasional dry cough. She denied hemoptysis or any symptoms of asthma. The patient reported orthopnea, paroxysmal nocturnal dyspnea, lower limb edema, palpitations, lightheadedness and several episodes of loss of consciousness. She denied a history of deep vein thrombosis or pulmonary embolism, recurrent pneumonia, chronic sinusitis, tuberculosis exposure and infection. She also denied dysphagia or aspiration, any history of infection with coccidioidomycosis, histoplasmosis or any other fungal infection. She lives on a farm located in Montana with exposure history to horses, cows, dogs, chickens and pheasants. She denied black mould exposure or water damage in the house. She reported daily use of an indoor hot tub since 2020, with respiratory symptoms developing in temporal association with the commencement of this repeated exposure, being diagnosed as non‐fibrotic hypersensitivity pneumonitis in June 2023 that was clinically attributed to residential bird and mouldy hay exposures. She denied occupational exposure to chemicals, solvents, asbestos, silica, hard metals, dust and feathers and did not have down comforters in the house. She denied any symptoms of connective tissue disease. The patient had never smoked or been exposed to chemotherapy or chest radiation. She stated that flecainide was prescribed for her before, but she had no history of amiodarone use. Her father was diagnosed with interstitial lung disease; other family members unaffected. Pulmonary examination revealed bilateral basal crepitations, without wheezes or rhonchi and physical examination otherwise was normal. Pulmonary function tests performed in September 2023 demonstrated pre‐bronchodilator FEV1 of 2.4 L (90% predicted), FVC of 3.1 L (93% predicted), FEV1/FVC ratio of 75.3% (97% predicted), TLC of 7.3 L (128% predicted), RV of 4.2 L (198% predicted) and DLCO of 14.7 mL/min/mmHg (69% predicted). These findings demonstrated hyperinflation, air trapping and mildly reduced diffusing capacity. Repeat pulmonary function testing in September 2024 showed FEV1 of 2.6 L (97% predicted), FVC of 2.9 L (89% predicted), FEV1/FVC ratio of 79.2% (101% predicted), TLC of 7.12 L (125% predicted), RV of 4.3 L (201% predicted) and DLCO of 15.5 mL/min/mmHg (73% predicted), demonstrating similar findings. (Table 1—Values are presented as absolute value (% predicted)). TABLE 1Pulmonary function test results in September 2023 and September 2024.FEV1 (L)FVC (L)FEV1/FVC (L)TLC (L)RV (L)DLCO (mL/min/mmHg)September 20232.4 (90%)3.1 (93%)75.3 (97%)7.3 (128%)4.2 (198%)14.7 (69%)September 20242.6 (97%)2.9 (89%)79.2 (101%)7.12 (125%)4.3 (201%)15.5 (73%)Abbreviations: DLCO = diffusing capacity of the lung for carbon monoxide; FEV1 = forced expiratory volume in 1 s; FVC = forced vital capacity; RV = residual volume; TLC = total lung capacity. Pulmonary function test results in September 2023 and September 2024. Abbreviations: DLCO = diffusing capacity of the lung for carbon monoxide; FEV1 = forced expiratory volume in 1 s; FVC = forced vital capacity; RV = residual volume; TLC = total lung capacity. At the time of diagnosis, a 6‐min walk test demonstrated a walking distance of 379 m (80% predicted) and an end‐exercise oxygen saturation of 94%. Following treatment, a repeat 6‐min walk test performed in March 2025 demonstrated improvement in functional capacity, with a walking distance of 497 m (105% predicted) and a lowest recorded oxygen saturation of 99%. Baseline oxygen saturation, exertional heart‐rate measurements and Borg dyspnea scale ratings were not available. Echocardiogram performed in February 2025 revealed hyperdynamic left ventricular systolic function with an ejection fraction of 76%, dynamic left ventricular outflow tract obstruction (resting gradient 7 mmHg, increasing to 58 mmHg with Valsalva) and normal right ventricular systolic function. Estimated right ventricular systolic pressure was 30 mmHg. There was no significant valvular disease, pericardial effusion or left atrial enlargement. Serologic testing showed a positive ANA and rheumatoid factor, with negative anti‐CCP and SSA/SSB antibodies and no evidence of connective tissue disease. A hypersensitivity pneumonitis serologic panel was obtained and was negative for avian antigens, including pigeon serum, pigeon droppings/extract, cockatiel, parakeet and parrot. A complementary panel assessing IgG against common moulds and thermophilic actinomycetes showed values within the laboratory reference ranges: Alternaria tenuis /alternata IgG 2.2 mcg/mL (< 12.0 mcg/mL), Aspergillus fumigatus IgG 20.9 mcg/mL (< 46.0 mcg/mL), Aureobasidium pullulans IgG 2.9 mcg/mL (< 18.0 mcg/mL), Laceyella sacchari IgG 5.7 mcg/mL (< 25.0 mcg/mL), Micropolyspora faeni IgG 2.3 mcg/mL (< 5.0 mcg/mL), Penicillium chrysogenum IgG 19.6 mcg/mL (< 22.0 mcg/mL), Phoma betae IgG 3.4 mcg/mL (< 8.0 mcg/mL) and Trichoderma viride IgG 6.2 mcg/mL (< 10.0 mcg/mL). The complete blood count did not reveal eosinophilia. Right upper lobe surgical lung biopsy was performed (Figure 2), it showed airway‐centred and airspace variably sized loosely to well‐formed granulomas (predominately non‐necrotizing with rare necrotizing granulomas) with associated organizing pneumonia and intra‐alveolar fibrin accumulation together with patchy chronic cellular interstitial infiltrates. Rare Mycobacterium avium complex (MAC) was identified on an auramine‐rhodamine stain. Bronchoalveolar lavage (BAL) was negative. H&E showing airway‐centred loosely formed granulomas and organizing pneumonia (asterisks) with patchy chronic cellular interstitial infiltrates. The clinical presentation, imaging, pathology, exposure history and the timing of exposure were most consistent with HTL due to hypersensitivity pneumonitis in the setting of MAC exposure from chronic indoor hot tub use. Additional findings included dynamic left ventricular outflow tract obstruction concerning for hypertrophic cardiomyopathy, explaining her recurrent syncope and cardiac symptoms. She was initially treated with corticosteroids and mycophenolate mofetil, with transient improvement. However, imaging progression occurred over the following year despite immunosuppression. Given her ongoing hot tub exposure and the histopathology findings, a mixed mechanism of hypersensitivity pneumonitis with MAC infection was considered. She was counselled on strict avoidance of hot tub use and immunosuppression was tapered. Initiation of empiric antimycobacterial therapy was recommended. In September 2025, she was started on azithromycin, ethambutol and rifabutin. Following cessation of hot tub exposure and initiation of therapy, her respiratory symptoms markedly improved. Repeat CT imaging (Figure 1E,F) demonstrated complete resolution and she remained clinically stable. Table 2, demonstrates chronological clinical timeline of diagnosis, treatment and outcomes. TABLE 2Chronological clinical timeline of diagnosis, treatment and outcomes.DateEvent2020Began daily use of indoor hot tubJune 2023Symptom onset (flu‐like illness, dyspnea, desaturation); first CT: centrilobular ground‐glass nodules, mosaic attenuation; diagnosed with non‐fibrotic HP (attributed to pheasants/mould); started on prednisone + mycophenolateSeptember 2023PFTs: TLC 128%, RV 198%, DLCO 69% (hyperinflation, air trapping, mildly reduced diffusion capacity)September 2024Recurrent acute hypoxic respiratory failure; repeat PFTs: similar findings (TLC 125%, RV 201%, DLCO 73%); repeat CT: persistent centrilobular nodules and mosaic attenuationFebruary 2025Echocardiogram: dynamic LVOTO (resting gradient 7 mmHg → 58 mmHg with Valsalva), EF 76%March 20256‐min walk test: 497 m (105% predicted), no desaturationAugust 2025Referred to pulmonary clinic; detailed history reveals daily indoor hot tub use since June 2023; surgical lung biopsy: bronchiolocentric non‐necrotizing granulomas, rare MAC on auramine‐rhodamine stain; BAL culture negativeSeptember 2025Initiated triple antimycobacterial therapy: Azithromycin + Ethambutol + Rifabutin; hot tub use discontinuedFollow‐up (approx. 24 months post‐presentation)Complete radiological and clinical resolution on repeat CT (Figure 1E,F)Abbreviations: BAL = bronchoalveolar lavage; CT = computed tomography; EF = ejection fraction; HP = hypersensitivity pneumonitis; LVOTO = left ventricular outflow tract obstruction; MAC = Mycobacterium avium complex; PFT = pulmonary function test. Chronological clinical timeline of diagnosis, treatment and outcomes. Abbreviations: BAL = bronchoalveolar lavage; CT = computed tomography; EF = ejection fraction; HP = hypersensitivity pneumonitis; LVOTO = left ventricular outflow tract obstruction; MAC = Mycobacterium avium complex; PFT = pulmonary function test. Discussion HTL is a rare, diffuse granulomatous lung disease first described in 1997 by Kahana et al., when a young immunocompetent woman developed respiratory symptoms after exposure to a contaminated hot tub [7]. Since then, fewer than 100 cases have been reported worldwide, predominantly among healthy middle‐aged adults with equal sex distribution and a mean age of 46 years, with the timing of hot tub exposure ranging from 2 months to 17 years prior to symptom development; cough and dyspnea are the most common presenting symptoms [2, 3]. Establishing the diagnosis of HTL is often challenging, as its clinical and imaging features overlap with other different pulmonary conditions, making clear diagnostic criteria essential. According to Hanak et al. [3] the diagnostic criteria for HTL include persistent respiratory symptoms, diffuse ‘infiltrates’ on chest imaging, a history of hot tub exposure prior to illness, isolation of Mycobacterium avium complex (MAC) from respiratory secretions, environmental water or lung tissue and the exclusion of alternative causes. According to the American Thoracic Society [8], HTL can be diagnosed even without histopathology in case there is subacute onset of symptoms in a patient with prior hot tub exposure when cultures are positive for nontuberculous mycobacteria from respiratory samples and water and characteristic imaging findings are present. MAC can survive and proliferate in hot tub environments due to its capability of resisting chlorine and ability to form biofilms, which protect the bacteria from disinfectants and facilitate persistence in water systems [9]. They can survive temperatures up to 42°C, exceeding the temperatures of hot tubs [10]. The hydrophobic glycopeptidolipids (GPL) found on the surface of MAC are important in biofilm formation and intracellular survival within macrophages; this enables the bacteria to evade host immune responses [11, 12]. Inhalation of aerosolized MAC containing water droplets from hot tubs can lead to HTL (a type of hypersensitivity pneumonitis); in most cases, a granulomatous inflammatory reaction rather than an active infection [2, 13]. This immune‐mediated response involves alveolar and interstitial inflammation triggered by MAC antigens and this response is driven by repeated antigen inhalation causing sensitization in the patient [14]. HTL often mimics other conditions such as infection, pulmonary embolism or hypersensitivity pneumonitis, complicating diagnosis. As many patients do not correlate the association between their respiratory symptoms and hot tub use, it is crucial for clinicians to ask about this exposure in the process of evaluating the patients' respiratory symptoms [15]. Our case illustrates this diagnostic challenge; for 3 years, the patient was initially diagnosed with non‐fibrotic hypersensitivity pneumonitis from exposure to pheasants and mould hay. Despite treatment, the patient's symptoms failed to improve and only through detailed evaluation, the correct diagnosis of HTL was established. This case is distinguished from existing HTL literature by three features: [1] a competing pheasant/mouldy hay antigen source masking diagnosis for > 2 years despite fulfilling HP criteria; [2] negative BAL culture with MAC detected only on surgical biopsy auramine‐rhodamine stain (unlike most cases with positive BAL); and [3] failure of > 2 years immunosuppression with resolution only after triple antimycobacterial therapy, suggesting an infectious contribution in treatment‐refractory HTL. HTL pathophysiology has remained controversial throughout different reports and cases, with some authors describing it as a hypersensitivity pneumonitis triggered by aerosolized Mycobacterium avium complex antigens, while other authors represent it as a true mycobacterial infection or a mixed mechanism of both pathologies. Rickman et al. [16] described cases of HTL in which ceasing hot tub use alone, without the need of antimycobacterial therapy, resulted in improvement in symptoms and imaging findings, arguing for a hypersensitivity pneumonitis pathophysiology. Chhor et al. [17] reported a young, immunocompetent patient with HTL that remained symptomatic and MAC culture‐positive despite steroids and significant improvement occurred only after anti‐mycobacterial therapy, arguing for the infectious role of MAC in cases where HP therapy fails. Verma et al. [5] described two patients of HTL that illustrate this debate. One patient presented with a long course resembling chronic HP and the second developed acute symptoms similar to non‐fibrotic HP. Both cases shared clinical, imaging and histopathologic features of HP. The cultures from patient samples and hot tub components yielded MAC and M. fortuitum , which raise the possibility of direct mycobacterial involvement. The chronically ill patient required antimycobacterial therapy in addition to hot tub avoidance, resulting in significant lung function improvement, whereas the patient with acute disease improved with corticosteroids and exposure cessation alone. The authors concluded that HTL is a heterogeneous syndrome, in most cases being indistinguishable from HP, but they also emphasised strongly the role of nontuberculous mycobacterial exposure. Daito et al. [18] studied the immunologic responses in murine models to inhaled MAC organisms and found that the immune response (via TLR9‐MyD88 in lung dendritic cells) was consistent with a hypersensitivity pneumonitis mechanism, suggesting that exposure to MAC doesn't always contribute to the disease directly as infection. The underlying pathophysiology of HTL can vary; accordingly, the treatment strategy can also be different. The management initially starts with hot tub avoidance and eliminating the exposure, which will result in symptomatic improvement in some patients alone without requiring medical therapy [3]. The source of MAC causing HTL is mainly the bathtub inlets and the filter in the hot tub [19]. Based on this, in selected cases, environmental disinfection (pipeline cleaning, filter replacement or heating water to 70°C) has been reported to successfully eradicate MAC and prevent recurrence, especially if the patient is unwilling to eliminate hot tub exposure [20]. In cases where hot tub avoidance is insufficient or the symptoms are very severe, a different approach may be required. In most reported cases, HTL behaved like non‐fibrotic hypersensitivity pneumonitis, generally not requiring antimycobacterial therapy; systemic corticosteroids can be added for more severe or persistent symptoms. Many reports followed this approach and complete clinical and imaging resolution was accomplished. Antimycobacterial regimens (macrolide, ethambutol and rifamycin per ATS/IDSA MAC guidance) are typically reserved for patients with evidence suggesting MAC infection either in the biopsy or bronchoalveolar lavage (BAL) or failure to improve despite strict avoidance of hot tub and appropriate steroids [2, 3, 8, 16, 17]. In our case, the patient did not benefit from steroids and mycophenolate therapy initially and even after diagnosis and hot tub avoidance, her symptoms persisted. Antimycobacterial therapy was lastly prescribed to the patient, resulting in major clinical and radiological improvements. Chest CT imaging in HTL usually shows multifocal or diffuse centrilobular nodules, ground‐glass opacities and in some cases, air trapping on expiratory imaging, reflecting bronchiolocentric granulomas narrowing the bronchiolar lumens and impairing airflow. In a comprehensive study of 12 pathologically confirmed cases, nodules were present in 83% of patients, with 80% demonstrating a diffuse centrilobular distribution, while ground‐glass opacities were identified in 75% of patients with bilateral and symmetric involvement. The nodules were either well‐defined solid lesions or poorly defined ground‐glass nodules, in most cases involving more than 40% of the lungs, distributed randomly in the transaxial plane. These imaging findings resemble subacute hypersensitivity pneumonitis, caused by granulomatous inflammation within the bronchiolar walls and lumens [1, 3]. Histopathologic examination of the surgical lung biopsy specimen in our case demonstrated airway‐centred and airspace variably sized loosely to well‐formed granulomas, predominantly non‐necrotizing with rare necrotizing granulomas, associated with organizing pneumonia and intra‐alveolar fibrin accumulation, together with patchy chronic cellular interstitial infiltrates. A special stain for auramine‐rhodamine highlights a few rare mycobacteria in a few of the granulomas. These findings are similar to the characteristic pathological features of HTL in prior reports. In a published series of 21 patients with HTL in Minnesota [3], bronchiolocentric granulomatous inflammation was present in 85% of transbronchial biopsies and 100% in surgical lung biopsies; the granulomas were well‐formed and predominantly non‐necrotizing. The presence of organizing pneumonia characterised by airspace filling of mycopolysaccharide‐rich plugs of proliferating fibroblasts and alveolar septal thickening due to chronic inflammatory cell infiltrates, as observed in our case, was a common finding in HTL pathology. Acid‐fast stains were positive for MAC in only 12% of lung tissue specimens in the published series and MAC was isolated in only 44% of BAL samples. The negative BAL culture does not exclude the diagnosis of HTL, as this condition primarily represents a hypersensitivity pneumonitis due to inhalational exposure to MAC antigens, even though this wasn't the case in our patient reinforcing the concept that HTL represents a spectrum between immune mediated hypersensitivity and true infection. Gundacker et al. [4] reported numerous non‐necrotizing, well‐formed granulomas in bronchocentric distribution, with Mycobacterium avium isolated from tissue cultures despite negative histochemical stains for acid‐fast bacilli (AFB). A notable limitation of this case is the absence of microbiologic sampling from the hot tub water. Per ATS/IDSA diagnostic criteria [8] for HTL, isolation of MAC from the environmental water source represents an important confirmatory step. While the constellation of clinical features, hot tub exposure history, characteristic imaging and histopathologic findings with auramine‐rhodamine‐positive organisms support the diagnosis of HTL, the lack of environmental culture data precludes definitive microbiologic confirmation of the MAC source. Future evaluations of suspected HTL should include culture of hot tub water and filter components to fulfil complete diagnostic criteria and establish a causal link between the environmental source and the patient's disease. In conclusion, this case underscores that interstitial lung disease refractory to immunosuppression warrants systematic reassessment of both the antigen source and the underlying disease mechanism. Accurate recognition of MAC‐contaminated hot tub exposure combined with histopathologic evidence and clinical progression despite immunosuppression alone suggests a possible mixed immune‐mediated and infectious pathophysiology; however, definitive proof of active infection remains limited by the absence of positive BAL culture and environmental water sampling. This patient's complete resolution following triple‐drug therapy and exposure cessation emphasises the importance of targeted questioning about hot tub exposure during diagnostic evaluation of persistent interstitial lung disease. Author Contributions F.A. contributed to study conception, literature review, data interpretation and manuscript drafting. R.F. contributed to study conception, literature review and manuscript editing. Y.B. contributed to pathologic data interpretation and critical manuscript revision. M.G. contributed to radiologic interpretation and imaging analysis. A.A. contributed to infectious disease interpretation and antimicrobial management review. J.A. contributed to study supervision, critical revision and final approval of the manuscript. All authors reviewed and approved the final manuscript. Funding The authors have nothing to report. Ethics Statement Ethical approval was not required for this case report in accordance with local and national guidelines, as it does not constitute human subjects' research. Consent The authors declare that written informed consent was obtained for the publication of this manuscript and accompanying images using the consent form provided by the Journal. Conflicts of Interest The authors declare no conflicts of interest. Abualhommos F., Fetyani R., Butt Y., Gotway M., Almajali A., and Azar J., “Hot Tub Lung: Misdiagnosed Hypersensitivity Pneumonitis Revealing a Mycobacterial Aetiology—A Case Report and Literature Review,” Respirology Case Reports 14, no. 9 (2026): e70741, 10.1002/rcr2.70741. Associate Editor: Yet Khor Data Availability Statement No new datasets were generated or analyzed during this study. All data supporting the findings of this review are included within the article and its references. References Associated Data Data Availability Statement No new datasets were generated or analyzed during this study. All data supporting the findings of this review are included within the article and its references.